The Fund aims to achieve long term capital growth.
Name | % Net Assets |
---|---|
General Electric Co. | 2.7% |
Bank of America Corp. | 2.7% |
Sanofi-Synthelabo | 2.7% |
Pfizer Inc. | 2.3% |
France Telecom | 1.9% |
J.P. Morgan Chase & Co. | 1.8% |
Occidental Petroleum Corp. | 1.8% |
Microsoft Corp. | 1.8% |
Credit Suisse Group | 1.7% |
OCCIDENTAL PETROLEUM CORP | 1.7% |
Key | % Net Assets |
---|---|
General Electric Co. | 2.7% |
Bank of America Corp. | 2.7% |
Sanofi-Synthelabo | 2.7% |
Pfizer Inc. | 2.3% |
Other | 89.6% |
Date | 21-Nov-2024 |
---|---|
NAV | 1,554.70p |
Currency | GBP |
Change | 10.46p |
% | 0.68% |
YTD change | 236.91p |
YTD % | 17.98% |
Fund Inception | 14/02/1994 |
---|---|
Fund Manager | Mark Breedon / James Hand / Sandi Merwitz |
TER | 1.62 (31-Dec-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £100 |
Savings | £100 |
Charges | |
---|---|
Initial | 4.50% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.02 |
You are here: research